Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy-Reference-Cited by-同舟云学术

Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy

Published:2018-11 Issue:3 Volume:183 Page:364-374
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hay Kevin A.¹²^ORCID

Affiliation:

1. Department of Medicine; University of British Columbia; Vancouver BC USA

2. Fred Hutchinson Cancer Research Center; Seattle WA USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15644/fullpdf

Reference79 articles.

1. Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL;Abramson;Journal of Clinical Oncology,2018

2. T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma;Ali;Blood,2016

3. Pericytes regulate the blood-brain barrier;Armulik;Nature,2010

4. Interleukin 6-mediated endothelial barrier disturbances can be attenuated by blockade of the IL6 receptor expressed in brain microvascular endothelial cells;Blecharz-Lang;Translational Stroke Research,2018

5. The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct;Brandl;Cancer Immunology, Immunotherapy,2007

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation;Journal of Pain and Symptom Management;2024-02

2. Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort;Annals of Intensive Care;2024-01-31

3. Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy;Transplantation and Cellular Therapy;2024-01

4. Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?;Frontiers in Immunology;2023-11-22

5. Nanoparticle-Based Approaches for Treatment of Hematological Malignancies: a Comprehensive Review;AAPS PharmSciTech;2023-11-16